Failure of systemic N-acetyl cysteine to protect the rat lung against bleomycin toxicity
- PMID: 2451202
- DOI: 10.3109/00313028709103883
Failure of systemic N-acetyl cysteine to protect the rat lung against bleomycin toxicity
Abstract
In order to see whether systemically administered N-acetyl cysteine (NAC) could protect the lung from bleomycin lung injury, 24 rats were given a constant subcutaneous infusion of NAC (mean 195 mg.kg-1.day-1) for 7 days while 23 rats were given a similar volume of saline. Two days after the start of infusion, half of each group received an endotracheal injection of bleomycin and the other half received a similar volume of saline. All animals were killed 7 days after intratracheal injection and their lungs were prepared for wet-weight to dry-weight ratio (W:D) and morphometric assessment of histological changes. In animals given intratracheal saline, NAC infusion had no effect on weight gain, W:D or morphometry compared to those animals given saline infusions. However, all bleomycin-treated animals had obvious evidence of lung damage. Compared to either group of animals treated with intratracheal saline, the bleomycin-treated groups gained less weight (p less than 0.001), had a higher W:D (p less than 0.001) and an increase in the volume densities of alveolar and duct walls (p less than 0.001), intra-alveolar cells (p less than 0.05) and consolidation (p less than 0.001). There were no significant differences between the two bleomycin-treated groups in any parameter measured. It is concluded that administration of NAC by a constant subcutaneous infusion was not protective against bleomycin lung injury.
Similar articles
-
Inhibition of bleomycin lung toxicity by N-acetyl cysteine in the rat.Pathology. 1985 Jan;17(1):108-10. doi: 10.3109/00313028509063736. Pathology. 1985. PMID: 2582337
-
Deferoxamine infusion does not inhibit bleomycin-induced lung damage in the rat.Am Rev Respir Dis. 1988 Jun;137(6):1356-9. doi: 10.1164/ajrccm/137.6.1356. Am Rev Respir Dis. 1988. PMID: 2462374
-
Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats.Eur Respir J. 2001 Jun;17(6):1228-35. doi: 10.1183/09031936.01.00049701. Eur Respir J. 2001. PMID: 11491169
-
Protective effect of hypoxia on bleomycin lung toxicity in the rat.Am Rev Respir Dis. 1984 Aug;130(2):307-8. doi: 10.1164/arrd.1984.130.2.307. Am Rev Respir Dis. 1984. PMID: 6205617
-
The effect of bleomycin and oxygen on rat lung.Pathology. 1984 Apr;16(2):136-9. doi: 10.3109/00313028409059091. Pathology. 1984. PMID: 6205354
Cited by
-
Evaluation of N-acetylcysteine treatment in acute pancreatitis-induced lung injury.Inflamm Res. 2012 Jul;61(7):699-705. doi: 10.1007/s00011-012-0462-6. Epub 2012 Mar 23. Inflamm Res. 2012. PMID: 22453841
-
Bleomycin induces senescence and repression of DNA repair via downregulation of Rad51.Mol Med. 2024 Apr 22;30(1):54. doi: 10.1186/s10020-024-00821-y. Mol Med. 2024. PMID: 38649802 Free PMC article.
-
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.Br J Pharmacol. 2003 Mar;138(6):1037-48. doi: 10.1038/sj.bjp.0705138. Br J Pharmacol. 2003. PMID: 12684259 Free PMC article.
-
Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux.Autophagy. 2018;14(2):269-282. doi: 10.1080/15548627.2017.1409405. Epub 2018 Jan 29. Autophagy. 2018. PMID: 29172997 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources